BridgeMD
Tests treatment safety and results for Chronic Cough
Official title Efficacy of Behavioral Therapy for Chronic Refractory Cough
ClinicalTrials.gov ID: NCT07488598
What this study is testing
- What it's testing
- Chronic cough is defined as cough persisting for more than eight weeks. It is a common clinical problem that significantly impairs patients' physical, psychological, and social quality of life.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50
You may be able to join if
- Eligible participants are adults aged ≥18 years i.e. normal chest radiograph.
- participants with chronic cough persisting for more than eight weeks that is refractory to standard medical treatment for common causes of chronic...
- Participants are required to exhibit clinical features suggestive of laryngeal hyperresponsiveness, such as cough triggered by phonation, laughter...
You likely can't join if
- Patients are excluded if they are current smokers or had ceased smoking within six months
- patients have evidence of active pulmonary or cardiac disease, recent respiratory tract infection, recent angiotensin-converting enzyme inhibitor use.
- significant structural laryngeal pathology, neurological disorders affecting cough reflex control, or inability to comply with study procedures.
- Head \&neck pathology e.g sinusitis, glottal insufficiency or primary muscle tension dysphonia
The study team makes the final eligibility decision.
Where it's taking place
- Asyut, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Asyut, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.